Update on the role of C1GALT1 in cancer (Review)

被引:5
|
作者
Xia, Tong [1 ]
Xiang, Ting [1 ]
Xie, Hailong [1 ]
机构
[1] Univ South China, Hunan Prov Key Lab Tumor Cellular & Mol Pathol, Inst Canc Res, Sch Med, 28 Changsheng West Rd, Hengyang 421001, Hunan, Peoples R China
关键词
glycan; glycosylation; glycosyltransferase; core 1 beta 1,3-galactosyltransferase; T-synthase; HEPATOCELLULAR-CARCINOMA CELLS; PREDICTS POOR-PROGNOSIS; BREAST-CANCER; O-GLYCOSYLATION; EPH RECEPTORS; IN-VITRO; PROTEIN GLYCOSYLATION; MOLECULAR CHAPERONE; C-MET; SPONTANEOUS COLITIS;
D O I
10.3892/ol.2022.13217
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer remains one of the most difficult diseases to treat. In the quest for early diagnoses to improve patient survival and prognosis, targeted therapies have become a hot research topic in recent years. Glycosylation is the most common posttranslational modification in mammalian cells. Core 1 beta 1,3-galactosyltransferase (C1GALT1) is a key glycosyltransferase in the glycosylation process and is the key enzyme in the formation of the core 1 structure on which most complex and branched O-glycans are formed. A recent study reported that C1GALT1 was aberrantly expressed in tumors. In cancer cells, C1GALT1 is regulated by different factors. In the present review, the expression of C1GALT1 in different tumors and its possible molecular mechanisms of action are described and the role of C1GALT1 in cancer development is discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Role of RASA1 in cancer: A review and update
    Zhang, Yanhua
    Li, Yue
    Wang, Quanyue
    Su, Bo
    Xu, Hui
    Sun, Yang
    Sun, Pei
    Li, Rumeng
    Peng, Xiaochun
    Cai, Jun
    ONCOLOGY REPORTS, 2020, 44 (06) : 2386 - 2396
  • [32] Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
    Khiaowichit, Juthamas
    Talabnin, Chutima
    Dechsukhum, Chavaboon
    Silsirivanit, Atit
    Talabnin, Krajang
    LIFE-BASEL, 2022, 12 (02):
  • [33] Interaction between GALNT12 and C1GALT1 Associates with Galactose-Deficient IgAl and IgA Nephropathy
    Wang, Yan-Na
    Zhou, Xu-Jie
    Chen, Pei
    Yu, Gui-Zhen
    Zhang, Xue
    Hou, Ping
    Liu, Li-Jun
    Shi, Su-Fang
    Lv, Ji-Cheng
    Zhang, Hong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (03): : 545 - 552
  • [34] The O-glycosyltransferase C1GALT1 promotes EWSR1::FLI1 expression and is a therapeutic target for Ewing sarcoma
    Banday, Shahid
    Mishra, Alok K.
    Rashid, Romana
    Ye, Tianyi
    Ali, Amjad
    Li, Junhui
    Yustein, Jason T.
    Kelliher, Michelle A.
    Zhu, Lihua Julie
    Deibler, Sara K.
    Malonia, Sunil K.
    Green, Michael R.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [35] Targeted Disruption of Core 1 β1,3-galactosyltransferase (C1galt1) Induces Apical Endocytic Trafficking in Human Corneal Keratinocytes
    Guzman-Aranguez, Ana
    Woodward, Ashley M.
    Pintor, Jesus
    Argueeso, Pablo
    PLOS ONE, 2012, 7 (05):
  • [36] Cytokines Alter IgA1 O- Glycosylation by Dysregulating C1GalT1 and ST6GalNAc-II Enzymes*
    Suzuki, Hitoshi
    Raska, Milan
    Yamada, Koshi
    Moldoveanu, Zina
    Julian, Bruce A.
    Wyatt, Robert J.
    Tomino, Yasuhiko
    Gharavi, Ali G.
    Novak, Jan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (08) : 5330 - 5339
  • [37] C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv
    Kuo, Ting-Chun
    Wu, Ming-Hsun
    Yang, Shih-Hung
    Chen, Syue-Ting
    Hsu, Tzu-Wen
    Jhuang, Jie-Yang
    Liao, Ying-Yu
    Tien, Yu-Wen
    Huang, Min-Chuan
    ONCOGENE, 2021, 40 (07) : 1242 - 1254
  • [38] Anti-C1GALT1 Autoantibody Is a Novel Prognostic Biomarker for Patients With Head and Neck Cancer
    Lin, Mei-Chun
    Huang, Min-Chuan
    Lou, Pei-Jen
    LARYNGOSCOPE, 2021, 131 (01) : E196 - E202
  • [39] C1GALT1, Negatively Regulated by miR-181d-5p, Promotes Tumor Progression via Upregulating RAC1 in Lung Adenocarcinoma
    Dong, Xiaoxia
    Liu, Yongyu
    Deng, Xinzhou
    Shao, Jun
    Tian, Shuangyue
    Chen, Shuang
    Huang, Rongxin
    Lin, Ziao
    Chen, Chunli
    Shen, Li
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [40] SLC35A2 deficiency reduces protein levels of core 1 β-1,3-galactosyltransferase 1 (C1GalT1) and its chaperone Cosmc and affects their subcellular localization
    Wiertelak, Wojciech
    Chabowska, Karolina
    Szulc, Bozena
    Zadorozhna, Yelyzaveta
    Olczak, Mariusz
    Maszczak-Seneczko, Dorota
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2023, 1870 (05):